Depressed
6
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
Supplementing Inpatient Behavioral Activation Group Psychotherapy
The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression
Sensitivity to Ovarian Hormones and Depression in Adolescents
Evaluation of Dalia Solution For Depressed Patient
Stress Sensitivity and Reward Responsivity in Depression